Sinclair Pharma plc published this content on 29 January 2018 and is solely responsible for the information contained herein. Sinclair Pharma's Silhouette InstaLift received high scores in an Aesthetic Surgery Journal (ASJ) study assessing its efficacy and safety. The ASJ is a peer-reviewed journal that publishes clinical research on cosmetic surgery for the treatment of aesthetic conditions such as breast augmentation or liposuction. The survey found 96% of respondents to the ASJ's 100-patient survey said it was a tolerable treatment and 83% said InstaLift improves age-related changes.
Sinclair Pharma's Silhouette InstaLift received high scores in an Aesthetic Surgery Journal (ASJ) study assessing its efficacy and safety. The ASJ is a peer-reviewed journal that publishes clinical research on cosmetic surgery for the treatment of aesthetic conditions such as breast augmentation or liposuction. The survey found 96% of respondents to the ASJ's 100-patient survey said it was a tolerable treatment and 83% said InstaLift improves age-related changes.